Turkey's 1st Pediatric Patient to Receive the SynCardia Total Artificial Heart Celebrates 18th Birthday
Yusuf Enec Surpasses 8 Months of Support with the Freedom® Portable Driver
TUCSON, Ariz. – Aug. 1, 2013 – Turning 18 years old is an important milestone in any young man's life, but even more so for Yusuf Enec. This time last year, Yusuf wasn't sure he'd live to see it. However, thanks to the SynCardia temporary Total Artificial Heart, today he has the chance to celebrate.
"Before the operation, I was so weak that even turning newspaper pages was too difficult for me," said Yusuf. "But now, I can play soccer with my artificial heart."
Yusuf was diagnosed with end-stage heart failure affecting both sides of his heart (biventricular failure) in January 2012 at Dokuz Eylul University Hospital in Izmir, Turkey. His condition deteriorated quickly and he became dependent on inotropes, which are medicines that increase the force of the heart's contractions, and his kidneys began to fail.
On Oct. 17, 2012, Yusuf, then 17, became Turkey's first pediatric patient to receive the SynCardia Total Artificial Heart. The surgery was performed by Prof. Oztekin Oto in order to save Yusuf's life and bridge him to a heart transplant. His recovery went well and six weeks after the implant surgery, he was switched to the Freedom® portable driver, the world's first wearable power supply for the SynCardia Total Artificial Heart. He surpassed eight months of support with the Freedom driver on July 26.
"We have observed better quality of life and lower complication rates with the SynCardia Total Artificial Heart compared to other biventricular devices," said Prof. Oto. "This system is very good for pediatric patients suffering biventricular failure who have enough space for the Total Artificial Heart."
SynCardia recognizes and thanks Ufuk Yaranli and Natura Medikal Urunler Ltd., the Turkish distributor for the Total Artificial Heart, for their commitment and ongoing support of the six SynCardia Certified Centers in Turkey and the additional three Turkish hospitals currently undergoing SynCardia's four-phase certification process.
The Freedom portable driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S.
CAUTION – The Freedom portable driver is an investigational device, limited by United States law to investigational use.
About SynCardia Systems, LLC
SynCardia Systems, LLC in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart is used as a bridge to transplant, helping them survive until a matching donor heart becomes available. SynCardia also manufactures the Freedom® portable driver, which powers the SynCardia Total Artificial Heart and allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant.
Janelle Drumwright, email@example.com, (520) 547-7463